Skip to content
2000
Volume 5, Issue 1
  • ISSN: 2665-9786
  • E-ISSN: 2665-9794

Abstract

Background

Diabetes Mellitus (DM) can appear due to the absence of insulin (DM1-type 1) or poor response of cells to insulin (DM2-type 2). Even though DM1 cannot be controlled using general treatments, DM2 can be easily controlled or prevented using pharmaceuticals, nutraceuticals, or dietary practices. Ceylon cinnamon (Cinnamomum zeylanicum) is one such natural remedy that has been consumed against elevated blood glucose levels in the past. Cinnamon and different types of cinnamon extracts have been scientifically tested for their activities on the inhibition of α-amylase and α-glucosidase enzymes that are responsible for carbohydrate metabolism and are effective in blood glucose regulation. However, the combined effect of aqueous and ethanol extracts of cinnamon bark on blood glucose regulation is still lacking. In this study, Water Extract of Cinnamon (CWE), Ethanol Extracts of Cinnamon (hot ethanol extract of cinnamon-CHEE, cold ethanol extract of cinnamon-CEE, and 50% ethanol extract of cinnamon- CEE-50) were studied for their sugar-controlling properties.

Objectives

This study was performed to identify the efficacy of different cinnamon extracts on the inhibition of α-amylase and α-glucosidase enzymes, followed by animal studies to confirm the use of the extracts in nutraceutical formulations.

Methods

Water and ethanol-based extraction method was used to prepare cinnamon extracts. These extracts have been scientifically tested for their activities on the inhibition of α-amylase and α-glucosidase enzymes. Molecular docking studies were used to identify the binding of the active molecules to the substrate binding sites of α-amylase and α-glucosidase. time dependence postprandial blood glucose regulation studies have been performed with healthy Wistar male rats.

Results

Yields of the CHEE, CEE, and CWE were 14±2%, 12±2%, and 8±1% respectively. According to the LCMS data, the major component in the CEE was cinnamaldehyde. Both CWE and CEE were subjected to the Total Polyphenol assay (TPC) and Total Flavonoids (TFC) assays. The TPC of CWE and CEE were 117±1 mg (Gal)/g and 170±10 mg (Gal)/g, while the TFC of CWE and CEE were 359±1 mg (Qc)/g and 254±4 mg (Qc)/g, respectively. In the α-amylase inhibition assay, Acarbose; a known α-amylase inhibitor, and CEE showed IC values of 65.4 ppm and 2.6 ppm, while CWE failed to show inhibition against α-amylase. In the α-glucosidase inhibition assay, Acarbose; a known α-amylase inhibitor, CEE, and CWE showed IC values of 312 ppm, 4.5 ppm, and 1.3 ppm, respectively. time dependence postprandial blood glucose regulation studies that have been performed with healthy Wistar male rats showed a lowering of blood glucose concentrations by 22%, 11%, and 10% of glucose at 30 min, 60 min, and 90 min compared to the control group.

Conclusion

The CEE contains polyphenols and flavonoids and is effective in inhibiting both α-amylase and α-glucosidase. The CWE also contains polyphenols and a comparatively higher level of flavonoids and is effective in inhibiting α-glucosidase while not affecting α-amylase inhibition. Overall, the IC data, TPC data, and TFC data proposed that the inhibition of carbohydrate hydrolyzing enzymes by polyphenols may depend on the polarity of particular polyphenols. Based on the rat trials, it can be concluded that the 1:1 combination of CWE and CEE may be useful in formulating postprandial blood glucose level-regulating nutraceuticals.

Loading

Article metrics loading...

/content/journals/cnt/10.2174/0126659786277971240508050021
2024-05-30
2024-12-25
Loading full text...

Full text loading...

References

  1. Andrade-CettoA. Becerra-JiménezJ. Cárdenas-VázquezR. Alfa-glucosidase-inhibiting activity of some Mexican plants used in the treatment of type 2 diabetes.J. Ethnopharmacol.20081161273210.1016/j.jep.2007.10.031 18082348
    [Google Scholar]
  2. RomeoG.R. LeeJ. MullaC.M. NohY. HoldenC. LeeB.C. Influence of cinnamon on glycemic control in individuals with prediabetes: a randomized controlled trial.J. Endocr. Soc.2020411bvaa09410.1210/jendso/bvaa094 33123653
    [Google Scholar]
  3. VerspohlE.J. BauerK. NeddermannE. Antidiabetic effect ofCinnamomum cassia and Cinnamomum zeylanicum In vivo and In vitro.Phytother. Res.200519320320610.1002/ptr.1643 15934022
    [Google Scholar]
  4. WestmanE.C. Type 2 diabetes mellitus: A pathophysiologic perspective.Front. Nutr.2021870737110.3389/fnut.2021.707371 34447776
    [Google Scholar]
  5. PathakA. PathakR. Study of life style habits on risk of type 2 diabetes.Int. J. Appl. Basic Med. Res.201222929610.4103/2229‑516X.106349 23776819
    [Google Scholar]
  6. BlairM. Diabetes mellitus review.Urol. Nurs.2016361273610.7257/1053‑816X.2016.36.1.27 27093761
    [Google Scholar]
  7. HallerM.J. AtkinsonM.A. SchatzD. Type 1 diabetes mellitus: Etiology, presentation, and management.Pediatr. Clin. North Am.20055261553157810.1016/j.pcl.2005.07.006 16301083
    [Google Scholar]
  8. JanežA. GujaC. MitrakouA. Insulin therapy in adults with type 1 diabetes mellitus: A narrative review.Diabetes Ther.202011238740910.1007/s13300‑019‑00743‑7 31902063
    [Google Scholar]
  9. SalehiP. AsghariB. EsmaeiliM.A. DehghanH. GhaziI. α-Glucosidase and α-amylase inhibitory effect and antioxidant activity of ten plant extracts traditionally used in Iran for diabetes.J. Med. Plants Res.20137257266
    [Google Scholar]
  10. RangH. DaleM.M. RitterJ. MooreP. Pharmacology Churchill Livingstone.New York2003
    [Google Scholar]
  11. KimmelB. InzucchiS.E. Oral agents for type 2 diabetes: An update.Clin. Diabetes2005232647610.2337/diaclin.23.2.64
    [Google Scholar]
  12. NairS.S. KavrekarV. MishraA. In vitro studies on alpha amylase and alpha glucosidase inhibitory activities of selected plant extracts.Eur. J. Exp. Biol.20133128131
    [Google Scholar]
  13. ShihabudeenH.M.S. PriscillaD.H. ThirumuruganK. Cinnamon extract inhibits a-glucosidase activity and dampens postprandial glucose excursion in diabetic rats.Nutr. Metab.201181p11
    [Google Scholar]
  14. BeejmohunV. Peytavy-IzardM. MignonC. Acute effect of Ceylon cinnamon extract on postprandial glycemia: Alpha-amylase inhibition, starch tolerance test in rats, and randomized crossover clinical trial in healthy volunteers.BMC Complement. Altern. Med.201414135110.1186/1472‑6882‑14‑351 25249234
    [Google Scholar]
  15. ComanC. RuginaO.D. SocaciuC. Plants and natural compounds with antidiabetic action.Not. Bot. Horti Agrobot. Cluj-Napoca201240131432510.15835/nbha4017205
    [Google Scholar]
  16. RaiM.K. A review on some antidiabetic plants of India.Anc. Sci. Life1995143168180 22556695
    [Google Scholar]
  17. WasanaK.G.P. AttanayakeA.P. JayatilakaK.A.P.W. WeerarathnaT.P. Antidiabetic activity of widely used medicinal plants in the Sri Lankan traditional healthcare system: new insight to medicinal flora in Sri Lanka.Evid. Based Complement. Alternat. Med.2021202111210.1155/2021/6644004 33628307
    [Google Scholar]
  18. ChoudhuryH. PandeyM. HuaC.K. An update on natural compounds in the remedy of diabetes mellitus: A systematic review.J. Tradit. Complement. Med.20188336137610.1016/j.jtcme.2017.08.012 29992107
    [Google Scholar]
  19. SenevirathneB.S. JayasingheM.A. PavalakumarD. SiriwardhanaC.G. Ceylon cinnamon: a versatile ingredient for futuristic diabetes management.J Fut Foods20222212514210.1016/j.jfutfo.2022.03.010
    [Google Scholar]
  20. KimS.H. HyunS.H. ChoungS.Y. Anti-diabetic effect of cinnamon extract on blood glucose in db/db mice.J. Ethnopharmacol.20061041-211912310.1016/j.jep.2005.08.059 16213119
    [Google Scholar]
  21. QinB. NagasakiM. RenM. BajottoG. OshidaY. SatoY. Cinnamon extract prevents the insulin resistance induced by a high-fructose diet.Horm. Metab. Res.200436211912510.1055/s‑2004‑814223 15002064
    [Google Scholar]
  22. QinB. PanickarK.S. AndersonR.A. Cinnamon: Potential role in the prevention of insulin resistance, metabolic syndrome, and type 2 diabetes.J. Diabetes Sci. Technol.20104368569310.1177/193229681000400324 20513336
    [Google Scholar]
  23. BlahováJ. SvobodováZ. Assessment of coumarin levels in ground cinnamon available in the Czech retail market.ScientificWorldJournal201220121410.1100/2012/263851 22761548
    [Google Scholar]
  24. RanasingheP. GalappaththyP. Health benefits of Ceylon cinnamon (Cinnamomum zeylanicum): A summary of the current evidence.Ceylon Med. J.201661115
    [Google Scholar]
  25. RanasingheP. JayawardenaR. PigeraS. Evaluation of pharmacodynamic properties and safety of Cinnamomum zeylanicum (Ceylon cinnamon) in healthy adults: a phase I clinical trial.BMC Complement. Altern. Med.201717155010.1186/s12906‑017‑2067‑7 29282046
    [Google Scholar]
  26. SpenceC. Cinnamon: The historic spice, medicinal uses, and flavour chemistry.Int. J. Gastron. Food Sci.2023100858
    [Google Scholar]
  27. RanasingheP. GunatilakeM. GunapalaN. Effects of Cinnamomum zeylanicum (Ceylon cinnamon) on blood glucose and lipids in a diabetic and healthy rat model.Pharmacognosy Res.201242737910.4103/0974‑8490.94719 22518078
    [Google Scholar]
  28. AndersonR.A. Chromium and polyphenols from cinnamon improve insulin sensitivity.Proc. Nutr. Soc.2008671485310.1017/S0029665108006010 18234131
    [Google Scholar]
  29. AryaeianN. Khorshidi SedehiS. ArablouT. Polyphenols and their effects on diabetes management: A review.Med. J. Islam. Repub. Iran201731188689210.14196/mjiri.31.134 29951434
    [Google Scholar]
  30. TuzcuZ. OrhanC. SahinN. JuturuV. SahinK. Cinnamon polyphenol extract inhibits hyperlipidemia and inflammation by modulation of transcription factors in high-fat diet-fed rats.Oxid. Med. Cell. Longev.2017201711010.1155/2017/1583098 28396714
    [Google Scholar]
  31. HapsariN.R.P. WijayantiC. The potency of cinnamon as an anti-diabetic and anti-covid19 based on its mineral content and phenolic compounds.J. Phys. Conf. Ser.1751012105
    [Google Scholar]
  32. DubeyS. GaneshpurkarA. GaneshpurkarA. BansalD. DubeyN. Glycolytic enzyme inhibitory and antiglycation potential of rutin.Future J. Pharmac. Sci.20173215816210.1016/j.fjps.2017.05.005
    [Google Scholar]
  33. ObohG. OgunsuyiO.B. OgunbadejoM.D. AdefeghaS.A. Influence of gallic acid on α-amylase and α-glucosidase inhibitory properties of acarbose.Yao Wu Shi Pin Fen Xi2016243627634 28911570
    [Google Scholar]
  34. ShengZ. DaiH. PanS. WangH. HuY. MaW. Isolation and characterization of an α-glucosidase inhibitor from Musa spp. (Baxijiao) flowers.Molecules2014197105631057310.3390/molecules190710563 25045894
    [Google Scholar]
  35. UduwelaH. DeraniyagalaS. ThiripuranatharG. Antioxidant and anti-inflammatory potential of the aqueous extract of the peel of a sri lankan variety of nephelium lappaceum linn.World J. Pharm. Res.20198154166
    [Google Scholar]
  36. DissanayakeD. DeraniyagalaS.A. HettiarachchiC. ThiripuranatharG. The study of antioxidant and antibacterial properties of skin, seeds and leaves of the Sri Lankan variety of pumpkin.IOSR J. Pharm.201884348
    [Google Scholar]
  37. AkilenR. TsiamiA. DevendraD. RobinsonN. Glycated haemoglobin and blood pressure‐lowering effect of cinnamon in multi‐ethnic Type 2 diabetic patients in the UK: A randomized, placebo‐controlled, double‐blind clinical trial.Diabet. Med.201027101159116710.1111/j.1464‑5491.2010.03079.x 20854384
    [Google Scholar]
  38. CrawfordP. Effectiveness of cinnamon for lowering hemoglobin A1C in patients with type 2 diabetes: A randomized, controlled trial.J. Am. Board Fam. Med.200922550751210.3122/jabfm.2009.05.080093 19734396
    [Google Scholar]
  39. KhanA. SafdarM. Ali KhanM.M. KhattakK.N. AndersonR.A. Cinnamon improves glucose and lipids of people with type 2 diabetes.Diabetes Care200326123215321810.2337/diacare.26.12.3215 14633804
    [Google Scholar]
  40. MangB. WoltersM. SchmittB. Effects of a cinnamon extract on plasma glucose, HbA 1c, and serum lipids in diabetes mellitus type 2.Eur. J. Clin. Invest.200636534034410.1111/j.1365‑2362.2006.01629.x 16634838
    [Google Scholar]
  41. KhanR. KhanZ. ShahS.H. Cinnamon may reduce glucose, lipid and cholesterol level in type 2 diabetic individuals.Pak. J. Nutr.20109543043310.3923/pjn.2010.430.433
    [Google Scholar]
  42. SuppapitipornS KanpaksiN The effect of cinnamon cassia powder in type 2 diabetes mellitus.J Med Assoc Thail Chotma thangphaet200689S2005
    [Google Scholar]
  43. ZiegenfussT.N. HofheinsJ.E. MendelR.W. LandisJ. AndersonR.A. Effects of a water-soluble cinnamon extract on body composition and features of the metabolic syndrome in pre-diabetic men and women.J. Int. Soc. Sports Nutr.200632455310.1186/1550‑2783‑3‑2‑45 18500972
    [Google Scholar]
  44. JivrajM. MartiniL.G. ThomsonC.M. An overview of the different excipients useful for the direct compression of tablets.Pharm. Sci. Technol. Today200032586310.1016/S1461‑5347(99)00237‑0 10664574
    [Google Scholar]
  45. KikutaJ.I. KitamoriN. Effect of mixing time on the lubricating properties of magnesium stearate and the final characteristics of the compressed tablets.Drug Dev. Ind. Pharm.199420334335510.3109/03639049409050187
    [Google Scholar]
  46. AliJ. SaigalN. BabootaS. AhujaA. Microcrystalline cellulose as a versatile excipient in drug research.J. Young Pharm.200911610.4103/0975‑1483.51868
    [Google Scholar]
  47. ShangrawR.F. Compressed tablets by direct compression, Pharmaceutical dosage forms.Tablets19891195246
    [Google Scholar]
  48. AnilS.K. SonalS. VikasW. A review on effervescent tablet.Int Res J Modern Eng Technol Sci2022421132121
    [Google Scholar]
  49. PatelS.G. SiddaiahM. Formulation and evaluation of effervescent tablets: A review.J. Drug Deliv. Ther.20188629630310.22270/jddt.v8i6.2021
    [Google Scholar]
  50. SastryS.V. NyshadhamJ.R. FixJ.A. Recent technological advances in oral drug delivery: A review.Pharm. Sci. Technol. Today20003413814510.1016/S1461‑5347(00)00247‑9 10754543
    [Google Scholar]
  51. Subash BabuP. PrabuseenivasanS. IgnacimuthuS. Cinnamaldehyde: A potential antidiabetic agent.Phytomedicine2007141152210.1016/j.phymed.2006.11.005 17140783
    [Google Scholar]
  52. ZhangW. XuY. GuoF. MengY. LiM. Anti-diabetic effects of cinnamaldehyde and berberine and their impacts on retinol-binding protein 4 expression in rats with type 2 diabetes mellitus.Chin. Med. J.2008121212124212810.1097/00029330‑200811010‑00003 19080170
    [Google Scholar]
  53. ZhuR. LiuH. LiuC. Cinnamaldehyde in diabetes: A review of pharmacology, pharmacokinetics and safety.Pharmacol. Res.2017122788910.1016/j.phrs.2017.05.019 28559210
    [Google Scholar]
  54. AndersonR.A. BroadhurstC.L. PolanskyM.M. Isolation and characterization of polyphenol type-A polymers from cinnamon with insulin-like biological activity.J. Agric. Food Chem.2004521657010.1021/jf034916b 14709014
    [Google Scholar]
  55. ImK. IssacA. NmJ. NinanE. MaliakelB. KuttanR. Effects of the polyphenol content on the anti-diabetic activity of Cinnamomum zeylanicum extracts.Food Funct.2014592208222010.1039/C4FO00130C 25051315
    [Google Scholar]
  56. LiR. LiangT. XuL. LiY. ZhangS. DuanX. Protective effect of cinnamon polyphenols against STZ-diabetic mice fed high-sugar, high-fat diet and its underlying mechanism.Food Chem. Toxicol.20135141942510.1016/j.fct.2012.10.024 23127600
    [Google Scholar]
  57. HaywardN.J. McDougallG.J. FaragS. Cinnamon shows antidiabetic properties that are species-specific: effects on enzyme activity inhibition and starch digestion.Plant Foods Hum. Nutr.201974454455210.1007/s11130‑019‑00760‑8 31372918
    [Google Scholar]
  58. AdisakwattanaS. LerdsuwankijO. PoputtachaiU. MinipunA. SuparppromC. Inhibitory activity of cinnamon bark species and their combination effect with acarbose against intestinal α-glucosidase and pancreatic α-amylase.Plant Foods Hum. Nutr.201166214314810.1007/s11130‑011‑0226‑4 21538147
    [Google Scholar]
  59. KaushalJ. SinghG. AryaS.K. Emerging trends and future prospective in enzyme technology.In: Value-Addition in Food Products and Processing Through Enzyme Technology.Elsevier20224911
    [Google Scholar]
  60. KumariA. SinghK. KayasthaM. α-Amylase: General properties, mechanism and biotechnological applications: A review.Curr. Biotechnol.2012198107
    [Google Scholar]
  61. SitrinM.D. Digestion and absorption of carbohydrates and proteins.The gastrointestinal system: Gastrointestinal, nutritional and hepatobiliary physiology.Springer201413715810.1007/978‑94‑017‑8771‑0_6
    [Google Scholar]
  62. SmithM.E. MortonD.G. The digestive system: systems of the body series.Elsevier Health Sciences2011
    [Google Scholar]
  63. ConiffR. KrolA. Acarbose: A review of US clinical experience.Clin. Ther.1997191162610.1016/S0149‑2918(97)80069‑0 9083705
    [Google Scholar]
  64. MartinA.E. MontgomeryP.A. Acarbose: An α-glucosidase inhibitor.Am. J. Health Syst. Pharm.199653192277229010.1093/ajhp/53.19.2277 8893066
    [Google Scholar]
  65. RosakC. MertesG. Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations.Diabetes Metab. Syndr. Obes.2012535736710.2147/DMSO.S28340 23093911
    [Google Scholar]
  66. AbbasG. Al-HarrasiA. HussainH. α-glucosidase enzyme inhibitors from natural products.In: Discovery and Development of Antidiabetic Agents from Natural Products.Elsevier 201625169
    [Google Scholar]
  67. AssefaS.T. YangE.Y. ChaeS.Y. Alpha glucosidase inhibitory activities of plants with focus on common vegetables.Plants201991210.3390/plants9010002 31861279
    [Google Scholar]
  68. TerraW.R. FerreiraC. Biochemistry and molecular biology of digestion.Insect molecular biology and biochemistry.Elsevier201236541810.1016/B978‑0‑12‑384747‑8.10011‑X
    [Google Scholar]
  69. MillerN. JoubertE. Critical assessment of in vitro screening of α-glucosidase inhibitors from plants with acarbose as a reference standard.Planta Med.202288121078109110.1055/a‑1557‑7379 34662924
    [Google Scholar]
  70. Rabasa‐LhoretR ChiassonJ L α‐Glucosidase inhibitors, International textbook of diabetes mellitus.Wiley Online Library2003
    [Google Scholar]
  71. HullattiK. TelagariM. In-vitro α-amylase and α-glucosidase inhibitory activity of adiantum caudatum linn. and celosia argentea linn. extracts and fractions.Indian J. Pharmacol.201547442542910.4103/0253‑7613.161270 26288477
    [Google Scholar]
  72. ShenX. SaburiW. GaiZ. Structural analysis of the α-glucosidase HaG provides new insights into substrate specificity and catalytic mechanism.Acta Crystallogr. D Biol. Crystallogr.20157161382139110.1107/S139900471500721X 26057678
    [Google Scholar]
  73. WilliamsL.K. ZhangX. CanerS. The amylase inhibitor montbretin A reveals a new glycosidase inhibition motif.Nat. Chem. Biol.201511969169610.1038/nchembio.1865 26214255
    [Google Scholar]
  74. AleixandreA. GilJ.V. SineiroJ. RosellC.M. Understanding phenolic acids inhibition of α-amylase and α-glucosidase and influence of reaction conditions.Food Chem.202237213123110.1016/j.foodchem.2021.131231 34624776
    [Google Scholar]
  75. ObohG. AdemosunA.O. AyeniP.O. OmojokunO.S. BelloF. Comparative effect of quercetin and rutin on α-amylase, α-glucosidase, and some pro-oxidant-induced lipid peroxidation in rat pancreas.Comp. Clin. Pathol.20152451103111010.1007/s00580‑014‑2040‑5
    [Google Scholar]
  76. TonsicB.R. CorreaV.G. Garcia-ManieriJ.A.A. BrachtA. PeraltaR.M. An in vivo approach to the reported effects of phenolic acids and flavonoids on the pancreatic α-amylase activity.Food Biosci.20235110235710.1016/j.fbio.2023.102357
    [Google Scholar]
/content/journals/cnt/10.2174/0126659786277971240508050021
Loading
/content/journals/cnt/10.2174/0126659786277971240508050021
Loading

Data & Media loading...


  • Article Type:
    Research Article
Keyword(s): Cinnamon; diabetes; extract; nutraceuticals; α-amylase; α-glucosidase
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test